A multicentre, prospective, pilot study of Sofosbuvir, Ledipasvir with and without Ribavirin in the treatment of chronic hepatitis C in patients with moderate to severe inflammatory bowel disease

Trial Profile

A multicentre, prospective, pilot study of Sofosbuvir, Ledipasvir with and without Ribavirin in the treatment of chronic hepatitis C in patients with moderate to severe inflammatory bowel disease

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2016

At a glance

  • Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms Solataire C
  • Most Recent Events

    • 23 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top